Year
Edition number
№14 / 2019
REVIEWS
O.D. Ostroumova (1, 2), I.V. Goloborodova (2)
Hypoglycemic drugs and drug-induced heart failure10-21
A.F. Verbovoy, I.A. Tsanava, N.I Verbovaya., Yu.A. Dolgikh
The polymorbidity and hypothyroidism22-28
M.V. Leonova
Statins and the risk of diabetes: an evidence-based review30-38
A.F. Verbovoy, I.A. Tsanava
The importance of adipokines in clinical practice40-46
ORIGINAL ARTICLES
N.A. Demidov (1), O.M. Koteshkova (2), M.A. Balberova (3), M.B. Antsiferov (2)
Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference?47-53
M.B. Antsiferov (1), N.A. Demidov (2)
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals54-58
N.A. Demidov (1), M.A. Balberova (2), M.B. Antsiferov (3)
What can affect the effectiveness of basal insulin therapy for patients with type 2 diabetes mellitus: analysis of the results of real clinical practice according to the diabetes register60-66
N.V. Vorokhobina (1), Y.S. Lovkova (2), A.V. Kuznetsova (1), Y.V. Kovalyova (1), N.V. Ivanov (1)
Risk of recurrent thyrotoxicosis and the incidence of obstetric complications in pregnant women with diffuse toxic goiter67-73
O.D. Ostroumova (1, 2), V.O. Kachan (3), A.I. Kochetkov (1)
Drug-induced hyperthyroidism74-80
A.S. Ametov (1), E.A. Tertychnaya (2)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance82-89
I.A. Ilovaiskaya (1, 2)
Difficult patient with acromegaly: expanding horizons of opportunities90-95
